C4 Therapeutics, Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q4 2019 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
C4 Therapeutics, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q4 2019 to Q3 2024.
  • C4 Therapeutics, Inc. Operating Lease, Right-of-Use Asset for the quarter ending September 30, 2024 was $59.2M, a 9.7% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $59.2M -$6.35M -9.7% Sep 30, 2024 10-Q 2024-10-31
Q2 2024 $60.8M -$6.29M -9.37% Jun 30, 2024 10-Q 2024-08-01
Q1 2024 $62.4M -$6.22M -9.07% Mar 31, 2024 10-Q 2024-05-08
Q4 2023 $64M -$6.16M -8.79% Dec 31, 2023 10-Q 2024-10-31
Q3 2023 $65.5M -$6.1M -8.52% Sep 30, 2023 10-Q 2023-11-01
Q2 2023 $67.1M -$6.06M -8.28% Jun 30, 2023 10-Q 2023-08-08
Q1 2023 $68.6M -$6.23M -8.32% Mar 31, 2023 10-Q 2023-05-04
Q4 2022 $70.1M +$38.2M +119% Dec 31, 2022 10-K 2024-02-22
Q3 2022 $71.6M +$59.4M +485% Sep 30, 2022 10-Q 2022-11-03
Q2 2022 $73.1M +$60.5M +481% Jun 30, 2022 10-Q 2022-08-04
Q1 2022 $74.8M +$61.9M +480% Mar 31, 2022 10-Q 2022-05-05
Q4 2021 $31.9M +$18.7M +141% Dec 31, 2021 10-K 2023-02-23
Q3 2021 $12.2M -$1.3M -9.56% Sep 30, 2021 10-Q 2021-11-10
Q2 2021 $12.6M Jun 30, 2021 10-Q 2021-08-11
Q1 2021 $12.9M Mar 31, 2021 10-Q 2021-05-13
Q4 2020 $13.2M -$1.22M -8.47% Dec 31, 2020 10-K 2022-02-24
Q3 2020 $13.5M Sep 30, 2020 10-Q 2020-11-12
Q4 2019 $14.5M Dec 31, 2019 10-K 2021-03-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.